ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Macrophage"

  • Abstract Number: 2145 • 2016 ACR/ARHP Annual Meeting

    The Modulation of Macrophage Polarization By SIRT1 Maybe New Target Therapy in Rheumatoid Arthritis

    Sang-Yeob Lee1, Won Tae Chung2, Sung Won Lee3, So Youn Park4 and Bae Jae Ho5, 1Cell Biology, Dong -A university, South Korea, Pusan, South Korea, 2Rheumatology, Dong-A University Hospital, Busan, South Korea, 3Dong-A university,Busan, South Korea, Pusan, South Korea, 4Medical Research Center for Ischemic Tissue Regeneration, Pusan national university, Yong -San, South Korea, 5department of biochemistry, medical college, Pusan National University,, MD, PhD, Gyeongsangnam-do, South Korea

    Background/Purpose: The polarization of macrophages was the expressed to M1/M2 phenotype by various stimuli or environment signals. The M1 macrophage was pro-inflammatory phenotype and was…
  • Abstract Number: 2267 • 2016 ACR/ARHP Annual Meeting

    AMP-Activated Protein Kinase: A  Target for Methotrexate in Macrophages

    Cornelia Cudrici1, Martin Pelletier2 and Richard M. Siegel3, 1NIAMS, Immunoregulation Section, Autoimmunity Branch, Bethesda, MD, 2Infectious and immune diseases Centre Hospitalier de l'Université Laval (CHUL) Québec, Québec, QC, Canada, 3National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD

    Background/Purpose: Methotrexate (MTX) remains a cornerstone of treatment in multiple forms of inflammatory arthritis, lupus and vasculitis. The anti-inflammatory effects of MTX are more likely…
  • Abstract Number: 2414 • 2016 ACR/ARHP Annual Meeting

    Microrna Associated with Active Systemic Juvenile Idiopathic Arthritis Regulate CD163 Expression in Polarized Macrophages through Two Distinct Mechanisms

    Thuy Do1, Rachel Tan2, Mark Bennett2, Mario Medvedovic2, Nan Shen3, Sherry Thornton1, Alexei Grom1 and Grant Schulert4, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2University of Cincinnati, Cincinnati, OH, 3Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    Background/Purpose:  CD163 is a hemoglobin scavenger receptor and innate pattern recognition receptor, and a marker of activated monocytes and macrophages. It is also expressed on…
  • Abstract Number: 2419 • 2016 ACR/ARHP Annual Meeting

    Single-Cell Analysis of CD163 mRNA and Protein Expression By Primeflow™ in Polarized Monocyte and Macrophage Populations

    Rachel Tan1, Sherry Thornton2, Alyssa Sproles2, Thuy Do3, Jonathan Schick4, Monica DeLay4 and Grant Schulert5, 1University of Cincinnati, Cincinnati, OH, 2Division of Rheumatology, Cincinnati Children's Hospital, Cincinnati, OH, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Cincinnati Children's Hospital, Cincinnati, OH, 5Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    Background/Purpose:  CD163 is involved in the regulation and resolution of innate inflammation and the removal of free hemoglobin from the blood via internalization of the…
  • Abstract Number: 186 • 2016 ACR/ARHP Annual Meeting

    Impact of TLR Stimulation on Cytokine Production in Macrophage Subsets: TLR2 Stimulation Impairs Anti-Inflammatory Activity of M2 Macrophages

    Lilian Quero, Anke Gehringer and Diego Kyburz, Department of Biomedicine, Experimental Rheumatology, University of Basel, 4051 Basel, Switzerland

    Background/Purpose: Toll-like receptors (TLRs) have been shown to contribute to the inflammatory response in rheumatoid arthritis (RA). A number of TLRs have been found to…
  • Abstract Number: 2619 • 2016 ACR/ARHP Annual Meeting

    Sustained Suppression of Peripheral Biomarkers By Mavrilimumab but Not Golimumab in Anti-Tumor Necrosis Factor-Inadequate Responders: An Exploratory Analysis in the Phase IIb Earth Explorer 2 Clinical Trial

    Xiang Guo1, Shiliang Wang1, Anne C. Bay-Jensen2, Morten Asser Karsdal2, A Godwood3, Marius Albulescu3, D Close3, Patricia C. Ryan1, Lorin Roskos4 and Wendy White1, 1Translational Sciences, MedImmune, LLC, Gaithersburg, MD, 2Rheumatology, Nordic Bioscience, Herlev, Denmark, 3MedImmune, Cambridge, United Kingdom, 4MedImmune, LLC, Mountain View, CA

    Background/Purpose: Treatment of rheumatoid arthritis (RA) patients by anti-tumour necrosis factors (anti-TNFs), such as golimumab, has improved patient outcomes. However, unmet therapeutic needs exist for…
  • Abstract Number: 461 • 2016 ACR/ARHP Annual Meeting

    Involvement of CD163-Positive Macrophages in the Pathogenesis of Arthritis Via Modulation of Inflammatory Cytokine and Chemokine Expression in the Synovium of a Murine Model

    Shinjiro Kaieda1, Hiroaki Ida2 and Tomoaki Hoshino3, 1Department of Medicine, *Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, kurume, Japan, 2Respiorogy, Neurology and Rheumatology, Kurume University School of Medicine, Kurume, Japan, 3Department of Medicine, Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, Kurume, Japan

    Background/Purpose:  Synovial-lining macrophages play a crucial role in the onset and maintenance of joint inflammation in arthritis. CD68 and CD163 are commonly used markers of…
  • Abstract Number: 2626 • 2016 ACR/ARHP Annual Meeting

    Soluble CD206 Plasma Levels Decreases with Treatment and Reflects Anti-Tnfa Discontinuation in Rheumatoid Arthritis

    Line Dam Heftdal1,2, Kristian Stengaard-Pedersen2, Merete Lund Hetland3,4, Kim Hørslev-Petersen5, Peter Junker6, Mikkel Østergaard4,7, Malene Hvid8,9, Bent Deleuran2,8,9, Holger Jon Møller8,10 and Stinne Greisen2,9, 1Department of Biomedicine, Department of Biomedicine, Aarhus University, Aarhus, Denmark, 2Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 3Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Denmark, Copenhagen, Denmark, 4Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark, Copenhagen, Denmark, 5King Christian X's Hospital for Rheumatic Diseases,, University of Southern Denmark, Graasten, Denmark, 6Department of Rheumatology, Odense University Hospital, Odense, Denmark, 7Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark, 8Department of Clinical Medicine, Aarhus University, Aarhus, Denmark, 9Department of Biomedicine, Aarhus University, Aarhus, Denmark, 10Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark

    Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation of the synovial joints and infiltration by activated macrophages. TNFa is a central…
  • Abstract Number: 580 • 2016 ACR/ARHP Annual Meeting

    Preferential Distribution of M1 Monocytes in Anti-Cyclic Citrullinated Peptide Antibody Positive Patients with Rheumatoid Arthritis

    Shoichi Fukui1, Naoki Iwamoto2, Toshimasa Shimizu2, Masataka Umeda2, Ayako Nishino3, Yoshiro Horai2, Tomohiro Koga4, Shin-ya Kawashiri5, Kunihiro Ichinose6, Yasuko Hirai2, Mami Tamai6, Hideki Nakamura5, Tomoki Origuchi7 and Atsushi Kawakami4, 1Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 2Department of Immunology and Rheumatology, Unit of Translational Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan, 3Department of Immunology and Rheumatology, Unit of Translational Medicine, Graduate School of Biomedical Sciences, Nagasaki Universit, Nagasaki, Japan, 4Unit of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 5Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 6Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 7Department of Rehabilitation Sciences, Nagasaki University, Nagasaki, Japan

    Background/Purpose: In rheumatoid arthritis (RA), bone erosions are caused mainly by osteoclasts. Osteoclasts are derived from monocytes and macrophages (MoMa). MoMa consists of different subtypes…
  • Abstract Number: 2703 • 2016 ACR/ARHP Annual Meeting

    Apremilast May Improve Atherosclerosis By Promoting Cholesterol Efflux and Inhibiting Foam Cell Formation in Atherosclerotic Plaques

    Hailing Liu1, Tuere Wilder2, Aranzazu Mediero3, Zhimin Wei1, Carmen Corciulo2 and Bruce Cronstein3, 1Medicine, NYU School of Medicine, New York, NY, 2Department of Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, 3Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY

    Background/Purpose:  Atherosclerosis is characterized by the accumulation of lipid-laden macrophages in the arterial walls. Patients with inflammatory arthritis and psoriasis are at greater risk of…
  • Abstract Number: 1010 • 2016 ACR/ARHP Annual Meeting

    Elucidating the Activation Profile of Systemic Sclerosis Macrophages

    Michael S. Ball1, Emilie P. Shipman1, Mohamed A. Eltanbouly1, Viktor Martyanov2, Kimberly A. Archambault3, Mary A. Carns4, Esperanza Arroyo4, Kathleen Aren4, Monique Hinchcliff5, Michael L. Whitfield2,3 and Patricia A. Pioli1, 1Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH, 2Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 3Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 4Department of Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, IL, 5Northwestern University, Feinberg School of Medicine Scleroderma Program, Chicago, IL

    Background/Purpose: Genome-wide gene expression studies implicate macrophages (MØs) as mediators of fibrosis in systemic sclerosis (SSc) and our data indicate that MØs constitute the dominant…
  • Abstract Number: 2718 • 2016 ACR/ARHP Annual Meeting

    Plasma Levels of the M2 Macrophage Markers, CD163 and CD206, Changes Reversely and Soluble CD163 Is Associated with Disease Activity in Spondyloarthritis

    Line Dam Heftdal1,2, René Østgård3,4, Malene Hvid3,5, Bent Deleuran2,3,5, Holger Jon Møller5 and Stinne Greisen2,3, 1Department of Biomedicine, Department of Biomedicine, Aarhus University, Aarhus, Denmark, 2Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 3Department of Biomedicine, Aarhus University, Aarhus, Denmark, 4Department of Rheumatology, Regional Hospital Silkeborg, Silkeborg, Denmark, 5Department of Clinical Medicine, Aarhus University, Aarhus, Denmark

    Background/Purpose: Spondyloarthritis (SpA) covers a group of interrelated auto-inflammatory disorders where TNFa is a central mediator of disease. T cells and macrophages are abundant in…
  • Abstract Number: 1030 • 2016 ACR/ARHP Annual Meeting

    Synovial Tissue Resident Macrophages Play the Protective Role in the Development of Inflammatory Arthritis in CD11c-Flip-KO Mice

    Qi Quan Huang1, Renee E. Doyle2, Robert Birkett3 and Richard M. Pope2, 1Division of Rheumatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Medicine/Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Medicine/Rheumatology, Northwestern University, Chicago, IL

    Synovial Tissue Resident Macrophages Play the protective role in the Development of Inflammatory Arthritis in CD11c-Flip-KO MiceQi-Quan Huang1, Renee Doyle1, Robert Birkett1 and Richard M.…
  • Abstract Number: 3071 • 2016 ACR/ARHP Annual Meeting

    Recombinant Human Proteoglycan-4 (rhPRG4) Inhibits Monosodium Urate (MSU) Crystal Phagocytosis By Human Macrophages and Resultant Inflammatory Response

    Marwa Qadri1, Tannin Schmidt2, Khaled Elsaid3 and Gregory Jay4, 1Pharmaceutical Sciences, Massachusetts College of Pharmacy and Health Sciences University, Boston, MA, 2Kinesiology and Schulich School of Engineering, University of Calgary, Calgary, AB, Canada, 3Biomedical and Pharmaceutical Sciences, Chapman University, Irvine, CA, 4Emergency Medicine, Brown University, Providence, RI

    Background/Purpose:   Gout is an inflammatory arthritis caused by precipitation of monosodium urate (MSU) crystals in synovial joints. MSU crystals interact with resident macrophages that…
  • Abstract Number: 1438 • 2016 ACR/ARHP Annual Meeting

    Tofacitinib Restores Reverse Cholesterol Transport Inhibition Induced By Inflammation. Understanding the Lipid Paradox

    Sandra Pérez-Baos1, Juan I. Barrasa2, Paula Gratal1, Ane Larrañaga-Vera1, Iván Prieto-Potin1, Gabriel Herrero-Beaumont1 and Raquel Largo1, 1Bone and Joint Research Unit, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain, 2Joint and Bone Research Unit, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain

    Background/Purpose:  Patients with active rheumatoid arthritis (RA) have significantly increased cardiovascular (CV) morbidity and mortality, paradoxically in association with reduced circulating levels of total cholesterol…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology